Back to News
investment

Italy’s Angelini Said to Explore Catalyst Pharma Acquisition

Manuel Baigorri, Dinesh Nair, Daniele Lepido
Loading...
1 min read
0 likes
⚡ Quantum Brief
Italian drugmaker Angelini Pharma is exploring a potential acquisition of Catalyst Pharmaceuticals Inc. as it looks at deals to expand its footprint globally, people familiar with the matter said.
AI Audio Summary
0:00 / 0:00
Click to play
Untitled design (19).png
Quantum News · Media Library

Italian drugmaker Angelini Pharma is exploring a potential acquisition of Catalyst Pharmaceuticals Inc. as it looks at deals to expand its footprint globally, people familiar with the matter said.

Read Original

Tags

drug-discovery
quantum-investment

Source Information

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.